Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-02-28FDA Approved: SYNAGIS — Supplemental Application (Swedish Orphan Biovitrum AB (publ))
FDA approved a supplemental application for Synagis (palivizumab) submitted by Swedish Orphan Biovitrum AB (publ).